English

KAZIA THERAPEUTICS LTD

EDGAR

KZIA Report (type unavailable) · filed 2026-09-22

Annual consolidated revenue for 2025: about AUD 42K, using the latest reported figures. The previous period, 2024, was about AUD 2.308M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

42 thousand AUD

2025 · AUD

Exact inputs and evidence

Revenue: 42000 AUD Source

Net margin

-49,290.48%

2025 · %

Exact inputs and evidence

Net Income: -20702000 AUD Source
Revenue: 42000 AUD Source

Operating cash flow

-13.3 million AUD

2025 · AUD

Exact inputs and evidence

Operating Cash Flow: -13278000 AUD Source

Free cash flow

-11.4 million AUD

2017 · AUD

Exact inputs and evidence

Operating Cash Flow: -11435000 AUD Source
Capital Expenditure: 12000 AUD Source

Cash and cash equivalents: 4.34 million AUD 2025-06-30 Source
Exact value

4344691 AUD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-09-22.

Financial data available through: 2025-06-30.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2025-06-30
operating income: No compatible figures in this window
Net income: 10 of 11 periods available· newest 2025-06-30
Operating cash flow: 10 of 11 periods available· newest 2025-06-30
Capital expenditure: 2 of 11 periods available· newest 2017-06-30
Total assets: 7 of 11 periods available· newest 2025-06-30
Total liabilities: 7 of 11 periods available· newest 2025-06-30
Current assets: 7 of 11 periods available· newest 2025-06-30
Current liabilities: 7 of 11 periods available· newest 2025-06-30
Cash and cash equivalents: 8 of 11 periods available· newest 2025-06-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-98.2%

Prior period

AUD 2.31 million

2023-07-01 – 2024-06-30
Current period

AUD 42,000

2024-07-01 – 2025-06-30

Exact inputs and evidence

42000 − 2308000 = -2266000 AUD

2308000 AUD · 2023-07-01 – 2024-06-30
Inspect prior input Prior source
42000 AUD · 2024-07-01 – 2025-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · KAZIA THERAPEUTICS LTD · 2025-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Year-over-year change in Revenue: -2266000 AUD Concept: fundies:Revenue Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 42000 AUD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#1448521 Filing: 000119312525272284 Input fundies:Revenue: 2308000 AUD (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#1448957 Filing: 000119312525272284
The citation records this snapshot. The page link may show a newer release later.
Net income
+AUD 6.08 million

Prior period

−AUD 26.78 million

2023-07-01 – 2024-06-30
Current period

−AUD 20.7 million

2024-07-01 – 2025-06-30

Exact inputs and evidence

-20702000 − -26778000 = 6076000 AUD

-26778000 AUD · 2023-07-01 – 2024-06-30
Inspect prior input Prior source
-20702000 AUD · 2024-07-01 – 2025-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · KAZIA THERAPEUTICS LTD · 2025-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Year-over-year change in Net income: 6076000 AUD Concept: fundies:NetIncome Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -20702000 AUD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#2889378 Filing: 000119312525272284 Input fundies:NetIncome: -26778000 AUD (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#2889828 Filing: 000119312525272284
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−AUD 3.7 million

Prior period

−AUD 9.58 million

2023-07-01 – 2024-06-30
Current period

−AUD 13.28 million

2024-07-01 – 2025-06-30

Exact inputs and evidence

-13278000 − -9581000 = -3697000 AUD

-9581000 AUD · 2023-07-01 – 2024-06-30
Inspect prior input Prior source
-13278000 AUD · 2024-07-01 – 2025-06-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · KAZIA THERAPEUTICS LTD · 2025-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Year-over-year change in Operating cash flow: -3697000 AUD Concept: fundies:OperatingCashFlow Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13278000 AUD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#1734565 Filing: 000119312525272284 Input fundies:OperatingCashFlow: -9581000 AUD (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#1735242 Filing: 000119312525272284
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2024-07-01 – 2025-06-30

Revenue AUD 42,000 100% of revenue
Operating costs Derived Unavailable An input is unavailable.
Operating income Unavailable An input is unavailable.
Tax, interest and other Derived Unavailable An input is unavailable.
Net income −AUD 20.7 million −49,290% of revenue

Cash

Operating cash flow −AUD 13.28 million −31,614% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2021 Not shown: operating income or net income is not reported.
2022 Not shown: operating income or net income is not reported.
2023 Not shown: operating income or net income is not reported.
2024 Not shown: operating income or net income is not reported.
2025 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2015-07-01 – 2016-06-30	406000	Unavailable	Unavailable	Unavailable	-12063000	-12502000 Derived	Source 2015-07-01 – 2016-06-30: 406000 AUD Inspect Revenue Open source 2015-07-01 – 2016-06-30: -12063000 AUD Inspect Net Income Open source 2015-07-01 – 2016-06-30: -11980000 AUD Inspect Operating Cash Flow Open source 2015-07-01 – 2016-06-30: 522000 AUD Inspect Capital Expenditure Open source
2017 2016-07-01 – 2017-06-30	249000	Unavailable	Unavailable	Unavailable	-10670000	-11447000 Derived	Source 2016-07-01 – 2017-06-30: 249000 AUD Inspect Revenue Open source 2016-07-01 – 2017-06-30: -10670000 AUD Inspect Net Income Open source 2016-07-01 – 2017-06-30: -11435000 AUD Inspect Operating Cash Flow Open source 2016-07-01 – 2017-06-30: 12000 AUD Inspect Capital Expenditure Open source
2018 2017-07-01 – 2018-06-30	119000	Unavailable	Unavailable	Unavailable	-6039000	Unavailable	Source 2017-07-01 – 2018-06-30: 119000 AUD Inspect Revenue Open source 2017-07-01 – 2018-06-30: -6039000 AUD Inspect Net Income Open source 2017-07-01 – 2018-06-30: -8660000 AUD Inspect Operating Cash Flow Open source
2021 2020-07-01 – 2021-06-30	15183000	Unavailable	Unavailable	Unavailable	-8420000	Unavailable	Source 2020-07-01 – 2021-06-30: 15183000 AUD Inspect Revenue Open source 2020-07-01 – 2021-06-30: -8420000 AUD Inspect Net Income Open source 2020-07-01 – 2021-06-30: -9111000 AUD Inspect Operating Cash Flow Open source
2022 2021-07-01 – 2022-06-30	0	Unavailable	Unavailable	Unavailable	-25014000	Unavailable	Source 2021-07-01 – 2022-06-30: 0 AUD Inspect Revenue Open source 2021-07-01 – 2022-06-30: -25014000 AUD Inspect Net Income Open source 2021-07-01 – 2022-06-30: -22762000 AUD Inspect Operating Cash Flow Open source
2023 2022-07-01 – 2023-06-30	0	Unavailable	Unavailable	Unavailable	-20465000	Unavailable	Source 2022-07-01 – 2023-06-30: 0 AUD Inspect Revenue Open source 2022-07-01 – 2023-06-30: -20465000 AUD Inspect Net Income Open source 2022-07-01 – 2023-06-30: -15156000 AUD Inspect Operating Cash Flow Open source
2024 2023-07-01 – 2024-06-30	2308000	Unavailable	Unavailable	Unavailable	-26778000	Unavailable	Source 2023-07-01 – 2024-06-30: 2308000 AUD Inspect Revenue Open source 2023-07-01 – 2024-06-30: -26778000 AUD Inspect Net Income Open source 2023-07-01 – 2024-06-30: -9581000 AUD Inspect Operating Cash Flow Open source
2025 2024-07-01 – 2025-06-30	42000	Unavailable	Unavailable	Unavailable	-20702000	Unavailable	Source 2024-07-01 – 2025-06-30: 42000 AUD Inspect Revenue Open source 2024-07-01 – 2025-06-30: -20702000 AUD Inspect Net Income Open source 2024-07-01 – 2025-06-30: -13278000 AUD Inspect Operating Cash Flow Open source

Amounts are exact, in AUD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

AUD 42K 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(AUD)	Source evidence
20162016-06-30	Revenue	406000	Revenue: 406000 Open source
20172017-06-30	Revenue	249000	Revenue: 249000 Open source
20182018-06-30	Revenue	119000	Revenue: 119000 Open source
20212021-06-30	Revenue	15183000	Revenue: 15183000 Open source
20222022-06-30	Revenue	0	Revenue: 0 Open source
20232023-06-30	Revenue	0	Revenue: 0 Open source
20242024-06-30	Revenue	2308000	Revenue: 2308000 Open source
20252025-06-30	Revenue	42000	Revenue: 42000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-98.2% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-06-30	Year over year	No prior comparable period	Revenue: 406000 Open source
20172017-06-30	Year over year	-38.7%	Revenue: 249000 Open source Revenue: 406000 Open source
20182018-06-30	Year over year	-52.2%	Revenue: 119000 Open source Revenue: 249000 Open source
20212021-06-30	Year over year	No prior comparable period	Revenue: 15183000 Open source
20222022-06-30	Year over year	-100%	Revenue: 0 Open source Revenue: 15183000 Open source
20232023-06-30	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20242024-06-30	Year over year	No prior comparable period	Revenue: 2308000 Open source Revenue: 0 Open source
20252025-06-30	Year over year	-98.2%	Revenue: 42000 Open source Revenue: 2308000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -49,290.5% 2025

Free cash flow margin -4,597.2% 2017

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2016-06-30	Operating margin	Not reported	Revenue: 406000 Open source
2017-06-30	Operating margin	Not reported	Revenue: 249000 Open source
2018-06-30	Operating margin	Not reported	Revenue: 119000 Open source
2021-06-30	Operating margin	Not reported	Revenue: 15183000 Open source
2022-06-30	Operating margin	Not reported	Revenue: 0 Open source
2023-06-30	Operating margin	Not reported	Revenue: 0 Open source
2024-06-30	Operating margin	Not reported	Revenue: 2308000 Open source
2025-06-30	Operating margin	Not reported	Revenue: 42000 Open source
20162016-06-30	Net margin	-2,971.2%	Net Income: -12063000 Open source Revenue: 406000 Open source
20172017-06-30	Net margin	-4,285.1%	Net Income: -10670000 Open source Revenue: 249000 Open source
20182018-06-30	Net margin	-5,074.8%	Net Income: -6039000 Open source Revenue: 119000 Open source
20212021-06-30	Net margin	-55.5%	Net Income: -8420000 Open source Revenue: 15183000 Open source
20222022-06-30	Net margin	Not reported	Net Income: -25014000 Open source Revenue: 0 Open source
20232023-06-30	Net margin	Not reported	Net Income: -20465000 Open source Revenue: 0 Open source
20242024-06-30	Net margin	-1,160.2%	Net Income: -26778000 Open source Revenue: 2308000 Open source
20252025-06-30	Net margin	-49,290.5%	Net Income: -20702000 Open source Revenue: 42000 Open source
20162016-06-30	Free cash flow margin	-3,079.3%	Revenue: 406000 Open source Operating Cash Flow: -11980000 Open source Capital Expenditure: 522000 Open source
20172017-06-30	Free cash flow margin	-4,597.2%	Revenue: 249000 Open source Operating Cash Flow: -11435000 Open source Capital Expenditure: 12000 Open source
20182018-06-30	Free cash flow margin	Not reported	Revenue: 119000 Open source Operating Cash Flow: -8660000 Open source
20212021-06-30	Free cash flow margin	Not reported	Revenue: 15183000 Open source Operating Cash Flow: -9111000 Open source
20222022-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -22762000 Open source
20232023-06-30	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -15156000 Open source
20242024-06-30	Free cash flow margin	Not reported	Revenue: 2308000 Open source Operating Cash Flow: -9581000 Open source
20252025-06-30	Free cash flow margin	Not reported	Revenue: 42000 Open source Operating Cash Flow: -13278000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

AUD -13.3M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(AUD)	Source evidence
20162016-06-30	Operating cash flow	-11980000	Operating Cash Flow: -11980000 Open source
20172017-06-30	Operating cash flow	-11435000	Operating Cash Flow: -11435000 Open source
20182018-06-30	Operating cash flow	-8660000	Operating Cash Flow: -8660000 Open source
20212021-06-30	Operating cash flow	-9111000	Operating Cash Flow: -9111000 Open source
20222022-06-30	Operating cash flow	-22762000	Operating Cash Flow: -22762000 Open source
20232023-06-30	Operating cash flow	-15156000	Operating Cash Flow: -15156000 Open source
20242024-06-30	Operating cash flow	-9581000	Operating Cash Flow: -9581000 Open source
20252025-06-30	Operating cash flow	-13278000	Operating Cash Flow: -13278000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

AUD -11.4M 2017

Values and sources

Free cash flow values and source evidence
Period	Series	Value(AUD)	Source evidence
20162016-06-30	Free cash flow	-12502000	Operating Cash Flow: -11980000 Open source Capital Expenditure: 522000 Open source
20172017-06-30	Free cash flow	-11447000	Operating Cash Flow: -11435000 Open source Capital Expenditure: 12000 Open source
20182018-06-30	Free cash flow	Unavailable	Operating Cash Flow: -8660000 Open source
20212021-06-30	Free cash flow	Unavailable	Operating Cash Flow: -9111000 Open source
20222022-06-30	Free cash flow	Unavailable	Operating Cash Flow: -22762000 Open source
20232023-06-30	Free cash flow	Unavailable	Operating Cash Flow: -15156000 Open source
20242024-06-30	Free cash flow	Unavailable	Operating Cash Flow: -9581000 Open source
20252025-06-30	Free cash flow	Unavailable	Operating Cash Flow: -13278000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

237% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2016-06-30	Liabilities / assets	Not reported	No source recorded
20172017-06-30	Liabilities / assets	29.4%	Total Liabilities: 10572000 Open source Total Assets: 35910000 Open source
20182018-06-30	Liabilities / assets	31.7%	Total Liabilities: 8933000 Open source Total Assets: 28175000 Open source
20212021-06-30	Liabilities / assets	34.8%	Total Liabilities: 20237000 Open source Total Assets: 58088000 Open source
20222022-06-30	Liabilities / assets	49.1%	Total Liabilities: 17614000 Open source Total Assets: 35889000 Open source
20232023-06-30	Liabilities / assets	57.1%	Total Liabilities: 16034000 Open source Total Assets: 28084000 Open source
20242024-06-30	Liabilities / assets	146.4%	Total Liabilities: 31602000 Open source Total Assets: 21585000 Open source
20252025-06-30	Liabilities / assets	237%	Total Liabilities: 14361125 Open source Total Assets: 6059676 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.35× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2016-06-30	Current assets / current liabilities	Not reported	No source recorded
20172017-06-30	Current assets / current liabilities	3.62×	Current Assets: 19480000 Open source Current Liabilities: 5384000 Open source
20182018-06-30	Current assets / current liabilities	2.38×	Current Assets: 9260000 Open source Current Liabilities: 3887000 Open source
20212021-06-30	Current assets / current liabilities	3.53×	Current Assets: 29391000 Open source Current Liabilities: 8327000 Open source
20222022-06-30	Current assets / current liabilities	1.4×	Current Assets: 9449000 Open source Current Liabilities: 6728000 Open source
20232023-06-30	Current assets / current liabilities	1.42×	Current Assets: 10772000 Open source Current Liabilities: 7565000 Open source
20242024-06-30	Current assets / current liabilities	0.24×	Current Assets: 6145000 Open source Current Liabilities: 25797000 Open source
20252025-06-30	Current assets / current liabilities	0.35×	Current Assets: 4933160 Open source Current Liabilities: 14052887 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2015-07-01 – 2016-06-30	−AUD 12.06 million Exact value Exact value: -12063000 AUD 2015-07-01 – 2016-06-30: -12063000 AUD Inspect Net Income Open source Share or cite Citation for Net Income · KAZIA THERAPEUTICS LTD · 2016-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Net Income: -12063000 AUD Concept: fundies:NetIncome Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ANetIncome&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=AUD&dimensions= Input fundies:NetIncome: -12063000 AUD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312518305893/kzia-20180630.xml#2337346 Filing: 000119312518305893 The citation records this snapshot. The page link may show a newer release later.	−AUD 11.98 million Exact value Exact value: -11980000 AUD 2015-07-01 – 2016-06-30: -11980000 AUD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KAZIA THERAPEUTICS LTD · 2016-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Operating Cash Flow: -11980000 AUD Concept: fundies:OperatingCashFlow Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3AOperatingCashFlow&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=AUD&dimensions= Input fundies:OperatingCashFlow: -11980000 AUD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312518305893/kzia-20180630.xml#2327629 Filing: 000119312518305893 The citation records this snapshot. The page link may show a newer release later.	AUD 522,000 Exact value Exact value: 522000 AUD 2015-07-01 – 2016-06-30: 522000 AUD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KAZIA THERAPEUTICS LTD · 2016-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Capital Expenditure: 522000 AUD Concept: fundies:CapitalExpenditure Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ACapitalExpenditure&period=2016-06-30&surface=latest&period_type=duration&start=2015-07-01&unit=AUD&dimensions= Input fundies:CapitalExpenditure: 522000 AUD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312518305893/kzia-20180630.xml#2338334 Filing: 000119312518305893 The citation records this snapshot. The page link may show a newer release later.	−AUD 12.5 million Calculation and evidence -11980000 − 522000 AUD Exact free cash flow: -12502000 AUD 2015-07-01 – 2016-06-30: -11980000 AUD · Inspect Operating Cash Flow · Source 2015-07-01 – 2016-06-30: 522000 AUD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KAZIA THERAPEUTICS LTD · 2016-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Free cash flow: -12502000 AUD Concept: free-cash-flow Period: 2015-07-01 to 2016-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11980000 AUD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312518305893/kzia-20180630.xml#2327629 Filing: 000119312518305893 Input fundies:CapitalExpenditure: 522000 AUD (2015-07-01 to 2016-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312518305893/kzia-20180630.xml#2338334 Filing: 000119312518305893 The citation records this snapshot. The page link may show a newer release later.
2017 2016-07-01 – 2017-06-30	−AUD 10.67 million Exact value Exact value: -10670000 AUD 2016-07-01 – 2017-06-30: -10670000 AUD Inspect Net Income Open source Share or cite Citation for Net Income · KAZIA THERAPEUTICS LTD · 2017-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Net Income: -10670000 AUD Concept: fundies:NetIncome Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ANetIncome&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=AUD&dimensions= Input fundies:NetIncome: -10670000 AUD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312519270437/kzia-20190630.xml#103349 Filing: 000119312519270437 The citation records this snapshot. The page link may show a newer release later.	−AUD 11.44 million Exact value Exact value: -11435000 AUD 2016-07-01 – 2017-06-30: -11435000 AUD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KAZIA THERAPEUTICS LTD · 2017-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Operating Cash Flow: -11435000 AUD Concept: fundies:OperatingCashFlow Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3AOperatingCashFlow&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=AUD&dimensions= Input fundies:OperatingCashFlow: -11435000 AUD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312519270437/kzia-20190630.xml#94714 Filing: 000119312519270437 The citation records this snapshot. The page link may show a newer release later.	AUD 12,000 Exact value Exact value: 12000 AUD 2016-07-01 – 2017-06-30: 12000 AUD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · KAZIA THERAPEUTICS LTD · 2017-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Capital Expenditure: 12000 AUD Concept: fundies:CapitalExpenditure Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ACapitalExpenditure&period=2017-06-30&surface=latest&period_type=duration&start=2016-07-01&unit=AUD&dimensions= Input fundies:CapitalExpenditure: 12000 AUD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312519270437/kzia-20190630.xml#105946 Filing: 000119312519270437 The citation records this snapshot. The page link may show a newer release later.	−AUD 11.45 million Calculation and evidence -11435000 − 12000 AUD Exact free cash flow: -11447000 AUD 2016-07-01 – 2017-06-30: -11435000 AUD · Inspect Operating Cash Flow · Source 2016-07-01 – 2017-06-30: 12000 AUD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · KAZIA THERAPEUTICS LTD · 2017-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Free cash flow: -11447000 AUD Concept: free-cash-flow Period: 2016-07-01 to 2017-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11435000 AUD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312519270437/kzia-20190630.xml#94714 Filing: 000119312519270437 Input fundies:CapitalExpenditure: 12000 AUD (2016-07-01 to 2017-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312519270437/kzia-20190630.xml#105946 Filing: 000119312519270437 The citation records this snapshot. The page link may show a newer release later.
2018 2017-07-01 – 2018-06-30	−AUD 6.04 million Exact value Exact value: -6039000 AUD 2017-07-01 – 2018-06-30: -6039000 AUD Inspect Net Income Open source Share or cite Citation for Net Income · KAZIA THERAPEUTICS LTD · 2018-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Net Income: -6039000 AUD Concept: fundies:NetIncome Period: 2017-07-01 to 2018-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ANetIncome&period=2018-06-30&surface=latest&period_type=duration&start=2017-07-01&unit=AUD&dimensions= Input fundies:NetIncome: -6039000 AUD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312520274018/kzia-20200630.xml#2233811 Filing: 000119312520274018 The citation records this snapshot. The page link may show a newer release later.	−AUD 8.66 million Exact value Exact value: -8660000 AUD 2017-07-01 – 2018-06-30: -8660000 AUD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KAZIA THERAPEUTICS LTD · 2018-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Operating Cash Flow: -8660000 AUD Concept: fundies:OperatingCashFlow Period: 2017-07-01 to 2018-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3AOperatingCashFlow&period=2018-06-30&surface=latest&period_type=duration&start=2017-07-01&unit=AUD&dimensions= Input fundies:OperatingCashFlow: -8660000 AUD (2017-07-01 to 2018-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312520274018/kzia-20200630.xml#223327 Filing: 000119312520274018 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2018-07-01 – 2019-06-30	−AUD 10.27 million Exact value Exact value: -10270000 AUD 2018-07-01 – 2019-06-30: -10270000 AUD Inspect Net Income Open source Share or cite Citation for Net Income · KAZIA THERAPEUTICS LTD · 2019-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Net Income: -10270000 AUD Concept: fundies:NetIncome Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ANetIncome&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=AUD&dimensions= Input fundies:NetIncome: -10270000 AUD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312521293688/d185056d20f.htm#2511502 Filing: 000119312521293688 The citation records this snapshot. The page link may show a newer release later.	−AUD 6.71 million Exact value Exact value: -6714000 AUD 2018-07-01 – 2019-06-30: -6714000 AUD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KAZIA THERAPEUTICS LTD · 2019-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Operating Cash Flow: -6714000 AUD Concept: fundies:OperatingCashFlow Period: 2018-07-01 to 2019-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3AOperatingCashFlow&period=2019-06-30&surface=latest&period_type=duration&start=2018-07-01&unit=AUD&dimensions= Input fundies:OperatingCashFlow: -6714000 AUD (2018-07-01 to 2019-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312521293688/d185056d20f.htm#2496860 Filing: 000119312521293688 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2019-07-01 – 2020-06-30	−AUD 12.47 million Exact value Exact value: -12467000 AUD 2019-07-01 – 2020-06-30: -12467000 AUD Inspect Net Income Open source Share or cite Citation for Net Income · KAZIA THERAPEUTICS LTD · 2020-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Net Income: -12467000 AUD Concept: fundies:NetIncome Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ANetIncome&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=AUD&dimensions= Input fundies:NetIncome: -12467000 AUD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312522263335/d251611d20f.htm#2582600 Filing: 000119312522263335 The citation records this snapshot. The page link may show a newer release later.	−AUD 8.81 million Exact value Exact value: -8810000 AUD 2019-07-01 – 2020-06-30: -8810000 AUD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KAZIA THERAPEUTICS LTD · 2020-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Operating Cash Flow: -8810000 AUD Concept: fundies:OperatingCashFlow Period: 2019-07-01 to 2020-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3AOperatingCashFlow&period=2020-06-30&surface=latest&period_type=duration&start=2019-07-01&unit=AUD&dimensions= Input fundies:OperatingCashFlow: -8810000 AUD (2019-07-01 to 2020-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312522263335/d251611d20f.htm#2571316 Filing: 000119312522263335 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2020-07-01 – 2021-06-30	−AUD 8.42 million Exact value Exact value: -8420000 AUD 2020-07-01 – 2021-06-30: -8420000 AUD Inspect Net Income Open source Share or cite Citation for Net Income · KAZIA THERAPEUTICS LTD · 2021-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Net Income: -8420000 AUD Concept: fundies:NetIncome Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ANetIncome&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=AUD&dimensions= Input fundies:NetIncome: -8420000 AUD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312523263551/d536161d20f.htm#2691095 Filing: 000119312523263551 The citation records this snapshot. The page link may show a newer release later.	−AUD 9.11 million Exact value Exact value: -9111000 AUD 2020-07-01 – 2021-06-30: -9111000 AUD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KAZIA THERAPEUTICS LTD · 2021-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Operating Cash Flow: -9111000 AUD Concept: fundies:OperatingCashFlow Period: 2020-07-01 to 2021-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3AOperatingCashFlow&period=2021-06-30&surface=latest&period_type=duration&start=2020-07-01&unit=AUD&dimensions= Input fundies:OperatingCashFlow: -9111000 AUD (2020-07-01 to 2021-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312523263551/d536161d20f.htm#2675473 Filing: 000119312523263551 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2021-07-01 – 2022-06-30	−AUD 25.01 million Exact value Exact value: -25014000 AUD 2021-07-01 – 2022-06-30: -25014000 AUD Inspect Net Income Open source Share or cite Citation for Net Income · KAZIA THERAPEUTICS LTD · 2022-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Net Income: -25014000 AUD Concept: fundies:NetIncome Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ANetIncome&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=AUD&dimensions= Input fundies:NetIncome: -25014000 AUD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312524259805/d872361d20f.htm#2772438 Filing: 000119312524259805 The citation records this snapshot. The page link may show a newer release later.	−AUD 22.76 million Exact value Exact value: -22762000 AUD 2021-07-01 – 2022-06-30: -22762000 AUD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KAZIA THERAPEUTICS LTD · 2022-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Operating Cash Flow: -22762000 AUD Concept: fundies:OperatingCashFlow Period: 2021-07-01 to 2022-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3AOperatingCashFlow&period=2022-06-30&surface=latest&period_type=duration&start=2021-07-01&unit=AUD&dimensions= Input fundies:OperatingCashFlow: -22762000 AUD (2021-07-01 to 2022-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312524259805/d872361d20f.htm#1534813 Filing: 000119312524259805 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2022-07-01 – 2023-06-30	−AUD 20.47 million Exact value Exact value: -20465000 AUD 2022-07-01 – 2023-06-30: -20465000 AUD Inspect Net Income Open source Share or cite Citation for Net Income · KAZIA THERAPEUTICS LTD · 2023-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Net Income: -20465000 AUD Concept: fundies:NetIncome Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ANetIncome&period=2023-06-30&surface=latest&period_type=duration&start=2022-07-01&unit=AUD&dimensions= Input fundies:NetIncome: -20465000 AUD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#2890278 Filing: 000119312525272284 The citation records this snapshot. The page link may show a newer release later.	−AUD 15.16 million Exact value Exact value: -15156000 AUD 2022-07-01 – 2023-06-30: -15156000 AUD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KAZIA THERAPEUTICS LTD · 2023-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Operating Cash Flow: -15156000 AUD Concept: fundies:OperatingCashFlow Period: 2022-07-01 to 2023-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3AOperatingCashFlow&period=2023-06-30&surface=latest&period_type=duration&start=2022-07-01&unit=AUD&dimensions= Input fundies:OperatingCashFlow: -15156000 AUD (2022-07-01 to 2023-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#1735918 Filing: 000119312525272284 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2023-07-01 – 2024-06-30	−AUD 26.78 million Exact value Exact value: -26778000 AUD 2023-07-01 – 2024-06-30: -26778000 AUD Inspect Net Income Open source Share or cite Citation for Net Income · KAZIA THERAPEUTICS LTD · 2024-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Net Income: -26778000 AUD Concept: fundies:NetIncome Period: 2023-07-01 to 2024-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ANetIncome&period=2024-06-30&surface=latest&period_type=duration&start=2023-07-01&unit=AUD&dimensions= Input fundies:NetIncome: -26778000 AUD (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#2889828 Filing: 000119312525272284 The citation records this snapshot. The page link may show a newer release later.	−AUD 9.58 million Exact value Exact value: -9581000 AUD 2023-07-01 – 2024-06-30: -9581000 AUD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KAZIA THERAPEUTICS LTD · 2024-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Operating Cash Flow: -9581000 AUD Concept: fundies:OperatingCashFlow Period: 2023-07-01 to 2024-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3AOperatingCashFlow&period=2024-06-30&surface=latest&period_type=duration&start=2023-07-01&unit=AUD&dimensions= Input fundies:OperatingCashFlow: -9581000 AUD (2023-07-01 to 2024-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#1735242 Filing: 000119312525272284 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2024-07-01 – 2025-06-30	−AUD 20.7 million Exact value Exact value: -20702000 AUD 2024-07-01 – 2025-06-30: -20702000 AUD Inspect Net Income Open source Share or cite Citation for Net Income · KAZIA THERAPEUTICS LTD · 2025-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Net Income: -20702000 AUD Concept: fundies:NetIncome Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3ANetIncome&period=2025-06-30&surface=latest&period_type=duration&start=2024-07-01&unit=AUD&dimensions= Input fundies:NetIncome: -20702000 AUD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#2889378 Filing: 000119312525272284 The citation records this snapshot. The page link may show a newer release later.	−AUD 13.28 million Exact value Exact value: -13278000 AUD 2024-07-01 – 2025-06-30: -13278000 AUD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · KAZIA THERAPEUTICS LTD · 2025-06-30 KAZIA THERAPEUTICS LTD (edgar:1075880) Operating Cash Flow: -13278000 AUD Concept: fundies:OperatingCashFlow Period: 2024-07-01 to 2025-06-30 Values: Latest reported Published: 2026-11-02T04:31:54Z Snapshot: 9b97c8bebbc6f07102ffa4f38ae9ccf05d8e6ceb3e5c0c9d356af4198d9e57af Dimensions: Consolidated View: https://fundies.io/companies/edgar/1075880/explain?concept=fundies%3AOperatingCashFlow&period=2025-06-30&surface=latest&period_type=duration&start=2024-07-01&unit=AUD&dimensions= Input fundies:OperatingCashFlow: -13278000 AUD (2024-07-01 to 2025-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1075880/000119312525272284/d908386d20f.htm#1734565 Filing: 000119312525272284 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

608 filings · 807 latest values · 807 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001075880, 1075880, KZIA, edgar:1075880

Also known as KAZIA THERAPEUTICS LTD, Kazia Therapeutics Limited, Kazia Therapeutics Limited., NOVOGEN LTD

KAZIA THERAPEUTICS LTD

Latest fiscal year

Revenue

Net margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2025 2024-07-01 – 2025-06-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation